Document is current
Any future updates will be listed below
-
Authors
Korenkov, M. https://orcid.org/0000-0002-2988-8483
Liebaert, J. https://orcid.org/0009-0009-7547-1222
Yousefian, S. https://orcid.org/0000-0003-0902-0369
Schwartz, S. https://orcid.org/0000-0001-8833-5793
Demel, U. M. https://orcid.org/0000-0002-6480-4185
Braune, J. https://orcid.org/0000-0003-2026-2641
Odabasi, M. C.
Herzberg, L.
Böckle, D.
Görür, N. C. https://orcid.org/0000-0001-7857-2461
v. Landenberg-Roberg, V.
Bohl, S.
Tregel, E.
Hennig, S.
Franke, C. https://orcid.org/0000-0002-5609-2472
Haas, S. https://orcid.org/0000-0001-9227-2051
Keller, U. https://orcid.org/0000-0002-8485-1958
Krönke, J.
Busse, A. https://orcid.org/0000-0002-3470-6947
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (HA 8790/3-1, KR 3886/7-1, HA 8790/3-1, KR 3886/7-1)
- License Information
-
More Information
Article History
Received: 3 June 2025
Revised: 29 August 2025
Accepted: 23 September 2025
First Online: 20 October 2025
Competing interests
: AB: Received honoraria not related to this manuscript from Novartis, Kite, MSD, AstraZeneca, and Takeda, as well as travel grants from Gilead, Takeda, and Janssen. JK: Advisory role, consulting, and travel support from Johnson & Johnson.
: Clinical data were retrospectively collected from health records following institutional approval (Ethikkommission der Charité – Universitätsmedizin Berlin: EA2/142/20). Informed consent was obtained from all participants. All methods were carried out in accordance with relevant guidelines and regulations.
